Qelbree Timing of Administration
Qelbree (viloxazine extended-release) should be taken once daily in the morning, though it can be taken at any time of day with or without food. 1
Dosing Flexibility
The FDA-approved prescribing information specifies that Qelbree is administered once daily and can be taken with or without food 1. The extended-release formulation is designed for single daily dosing, providing 24-hour symptom coverage.
Morning vs. Evening Administration
While the FDA label does not mandate a specific time of day, morning administration is generally preferred based on:
- Standard clinical practice: Most ADHD medications are taken in the morning to provide symptom control during waking hours
- Insomnia risk: Insomnia is one of the most common adverse effects in adults (reported frequently in clinical trials) 1, making evening dosing potentially problematic
- Recent evidence: A phase 4 study specifically evaluated morning versus evening dosing in children and adolescents taking Qelbree with psychostimulants 2. The study found that timing of administration (morning or evening) did not significantly affect safety, drug response, or sleep improvement, suggesting flexibility is acceptable
Administration Instructions
Key administration details 1:
- Swallow capsules whole (do not cut, crush, or chew)
- Alternative for those unable to swallow: Capsules may be opened and contents sprinkled on pudding or applesauce
- Swallow immediately without chewing
- Use within 15 minutes for pudding or 2 hours for applesauce
- Do not store the mixture
- Pharmacokinetic studies confirm that sprinkled administration produces equivalent bioavailability to intact capsules 3
Clinical Considerations
Factors influencing timing choice:
- If insomnia develops: Consider morning dosing to minimize sleep disruption
- If somnolence/fatigue occurs: Evening dosing may be better tolerated (somnolence affects 9.5% of pediatric patients) 1, 4
- Consistency matters: Once-daily dosing at the same time each day optimizes adherence
The extended-release formulation provides steady medication levels throughout the day regardless of timing, with improvements in ADHD symptoms typically observed within 2-3 weeks of treatment initiation 5, 6.